Health and Human Services Secretary Robert F. Kennedy Jr. publicly denied speculation that he is preparing a 2028 ...

FDA approved Papzimeos (zopapogene imadenovec), the first-in-class, non-replicating adenoviral vector-based immunotherapy, ...

This first approved medical therapy for RRP generates an immune response against the causative HPV strains. It uses ...

Health and Human Services Secretary Robert F. Kennedy Jr. pushed back on Friday against speculation he may run for president ...

The FDA has granted full approval to Precigen’s Papzimeos (zopapogene imadenovec-drba) for adults with recurrent respiratory papillomatosis (RRP). Papzimeos is a non-replicating adenoviral ...

HHS has reinstated the Safer Childhood Vaccines task force, the agency said in an Aug. 14 news release. Here are six things to know: 1. The task force, created by Congress, was originally disbanded in ...

The FDA approved the adenoviral vector-based immunotherapy, zopapogene imadenovec-drba, for treatment of certain patients ...

In RFK Jr.’s America, it will never be safe to practice public health or medicine," write an epidemiologist and a former CDC ...

The FDA’s announcement of Papzimeos’ approval contained an unusual quote from newly reinstated CBER director Vinay Prasad. Elsewhere, Eli Lilly and Superluminal Medicines struck a deal.

Dr Vinay Prasad will return to head the FDA’s Center for Biologics Evaluation and Research less than 2 weeks after being ousted.

Precigen's immunotherapy for a rare respiratory disease has become the first treatment to win U.S. regulatory approval for ...

The U.S. Food and Drug Administration has approved Precigen's immunotherapy to treat adults with a rare respiratory disease, making it the first treatment for the condition to receive the health ...